Benitec Biopharma (BNTC) Change in Cash (2019 - 2025)

Benitec Biopharma (BNTC) has 7 years of Change in Cash data on file, last reported at $94.3 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Cash rose 803.36% year-over-year to $94.3 million; the trailing twelve-month figure through Dec 2025 stood at $110.6 million (up 90.76% YoY), and the FY2025 full-year result was $46.9 million, down 3.12% from the prior year.
• Change in Cash advanced to $94.3 million in Q4 2025, from -$3.3 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $94.3 million in Q4 2025 to a low of -$6.2 million in Q1 2024.
• A 5-year average of $8.7 million and a median of -$3.3 million in 2021 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash sank 158.72% in 2022 and jumped 1002.4% in 2024, its largest moves.
• Tracing BNTC's Change in Cash over 5 years: stood at -$3.4 million in 2021, then sank by 76.46% to -$6.0 million in 2022, then rose by 8.46% to -$5.5 million in 2023, then surged by 290.2% to $10.4 million in 2024, then soared by 803.36% to $94.3 million in 2025.
• Business Quant data shows BNTC's Change in Cash at $94.3 million in Q4 2025, -$3.3 million in Q3 2025, and -$5.8 million in Q2 2025.